Get the Stockscreener App
5.71
12.85%
0.65
After Hours:
5.58
-0.13
-2.28%
Alvotech stock is traded at $5.71, with a volume of 1.01M.
It is up +12.85% in the last 24 hours and down -33.91% over the past month.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
See More
Previous Close:
$5.06
Open:
$5.45
24h Volume:
1.01M
Relative Volume:
2.00
Market Cap:
$1.58B
Revenue:
$391.87M
Net Income/Loss:
$-441.45M
P/E Ratio:
-3.0865
EPS:
-1.85
Net Cash Flow:
$-301.21M
1W Performance:
-25.36%
1M Performance:
-33.91%
6M Performance:
-28.09%
1Y Performance:
-54.90%
1-Day Range:
$5.42
$5.71
1-Week Range:
$4.70
$5.87
52-Week Range:
$4.70
$13.70
Alvotech Stock (ALVO) Company Profile
Compare ALVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
5.71 | 1.58B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
120.24 | 52.69B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.66 | 43.09B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.90B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
23.97 | 28.06B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
448.91 | 19.55B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-14-25 | Initiated | UBS | Buy |
| Jan-29-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Upgrade | Citigroup | Sell → Neutral |
| Sep-21-23 | Initiated | Barclays | Equal Weight |
| Sep-07-22 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-06-22 | Downgrade | Citigroup | Buy → Sell |
| Jul-26-22 | Initiated | Citigroup | Buy |
View All
Alvotech Stock (ALVO) Latest News
What MACD signals say about AlvotechJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com
Alvotech's (NASDAQ:ALVO) 31% Dip In Price Shows Sentiment Is Matching Revenues - simplywall.st
Lost Money on Alvotech (ALVO)? Contact Levi & Korsinsky About Fraud Investigation - ACCESS Newswire
Alvotech Stock Hits Day Low of $4.81 Amid Price Pressure - Markets Mojo
Alvotech (NASDAQ:ALVO) Shares Gap UpWhat's Next? - MarketBeat
How to escape a deep drawdown in Alvotech2025 Major Catalysts & Community Trade Idea Sharing - newser.com
Alvotech Equity Warrant stock daily chart insightsJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com
Alvotech faces FDA setback for its Simponi biosimilar AVT05 - MSN
Is Alvotech stock a smart buy before Fed meetingAnalyst Downgrade & Weekly High Return Stock Forecasts - newser.com
How Alvotech (Z45) stock trades under stagflation2025 Market Overview & Fast Moving Stock Watchlists - newser.com
ALVO ACTIVE INVESTIGATION: Lost Money on Alvotech? Contact Levi & Korsinsky Now - ACCESS Newswire
Does Alvotech’s 35% Weekly Drop Reveal a Rare Opportunity for 2025 Investors? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Is Investigating Alvotech (ALVO) And Encourages Stockholders to Connect - ACCESS Newswire
Alvotech (ALVO) Is Down 35.5% After FDA Delays Key AVT05 Biosimilar Approval—Has The Bull Case Changed? - Yahoo Finance
Alvotech Shares Plunge to New 52-Week Low of $4.81 - Markets Mojo
ALVOTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Alvotech on Behalf of Alvotech ... - Bluefield Daily Telegraph
Can Alvotech’s Sharp 61% Drop Signal a Value Opportunity After Regulatory Updates? - Yahoo Finance
Will Alvotech stock benefit from AI adoptionSwing Trade & Free Reliable Trade Execution Plans - newser.com
Alvotech and Advanz announce MHRA marketing authorisations for Gobivaz - Pharmaceutical Business review -
Alvotech and Advanz Pharma Receive UK MHRA Approval for All Four Formulations of Gobivaz - geneonline.com
Does Alvotech stock trade at a discount to peersJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com
Will Alvotech stock reach all time highs in 2025July 2025 Snapshot & Daily Entry Point Alerts - newser.com
Using economic indicators to assess Alvotech potentialAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com
What candlestick patterns are forming on Alvotech2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - newser.com
Has Alvotech formed a bullish divergenceJuly 2025 Closing Moves & Accurate Technical Buy Alerts - newser.com
Can technical indicators confirm Alvotech Equity Warrant’s reversalWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
How Recent Developments Are Rewriting the Story for Alvotech - Yahoo Finance
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into Alvotech (NASDAQ: ALVO) - GlobeNewswire
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into Alvotech (NASDAQ: ALVO) - GlobeNewswire Inc.
Alvotech’s Gobivaz Biosimilar Gains UK Approval - TipRanks
Alvotech, Advanz Pharma Receive MHRA Marketing Authorizations for Gobivaz - Contract Pharma
UK regulator approves Alvotech’s golimumab biosimilar for immune diseases By Investing.com - Investing.com Canada
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA - The Manila Times
Alvotech and Advanz Pharma Announce MHRA Marketing Authorisations for Biosimilar Gobivaz® in the UK - Quiver Quantitative
UK regulator approves Alvotech’s golimumab biosimilar for immune diseases - Investing.com
Alvotech and Advanz Pharma Receive Marketing Authorisations - GlobeNewswire
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz, a Biosimilar to Simponi (Golimumab), From the MHRA - 富途牛牛
Teva, Alvotech get FDA nod for Johnson & Johnson biosimilar - MSN
Alvotech (ALVO) to Release Earnings on Wednesday - MarketBeat
Is Alvotech stock positioned for digital transformationTrade Signal Summary & Smart Swing Trading Alerts - newser.com
Why Alvotech stock could outperform in 2025July 2025 News Drivers & AI Based Buy/Sell Signal Reports - newser.com
Trend analysis for Alvotech this weekEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
Will Alvotech (Z45) stock rise with strong economyJuly 2025 Breakouts & Real-Time Volume Analysis - newser.com
Analysts Just Slashed Their Alvotech (NASDAQ:ALVO) EPS Numbers - simplywall.st
Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in - MSN
Using economic indicators to assess Alvotech Equity Warrant potential2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
What technical patterns form on Alvotech (Z45) stock chartsWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
Will Alvotech stock maintain dividend yieldJuly 2025 Catalysts & Safe Entry Trade Signal Reports - fcp.pa.gov.br
Can Alvotech (Z45) stock survive global slowdownJuly 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - newser.com
Visual trend scoring systems applied to Alvotech Equity WarrantJuly 2025 Recap & Expert Curated Trade Ideas - newser.com
Why Alvotech stock could see breakout soonPortfolio Performance Report & Risk Managed Investment Signals - fcp.pa.gov.br
Alvotech Stock (ALVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):